Skip to main content

Table 2 SPECT and PET data

From: Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy

 

Baseline

12-month

Case 1 (PSP01)

R striatum = 0.16

R striatum = 0.19

L striatum = 0.14

L striatum = 0.16

R caudate nucleus = 0.27

R caudate nucleus = 0.10

L caudate nucleus = 0.17

L caudate nucleus = 0.23

R putamen = 0.08

R putamen = 0.27

L putamen = 0.10

L putamen = 0.09

Case 2 (PSP02)

R striatum = 0.49

R striatum = 0.34

L striatum = 0.35

L striatum = 0.21

R caudate nucleus = 0.59

R caudate nucleus = 0.48

L caudate nucleus = 0.39

L caudate nucleus = 0.33

R putamen = 0.42

R putamen = 0.1

L putamen = 0.35

L putamen = 0.01

Case 3 (PSP06)

R striatum = 0.42

na

L striatum = 0.60

R caudate nucleus = 0.54

L caudate nucleus = 0.73

R putamen = 0.30

L putamen = 0.43

Case 4 (PSP08)

R striatum = 1.00

R striatum = 0.61

L striatum = 1.15

L striatum = 0.72

R caudate nucleus = 1.30

R caudate nucleus = 0.67

L caudate nucleus = 1.46

L caudate nucleus = 0.72

R putamen = 0.79

R putamen = 0.55

L putamen = 0.86

L putamen = 0.65

Case 5 (PSP09)

R striatum = 0.37

na

L striatum = 0.46

R caudate nucleus = 0.37

L caudate nucleus = 0.55

R putamen = 0.36

L putamen = 0.39

  1. Specific striatal dopamine uptake transporter (DAT) binding of [123I] FP-CIT, calculated in the whole striatum, putamen and caudate nucleus using the formula: \(\left[ {\left( {\text{mean counts in specific ROI}} \right) - \left( {\text{mean counts in occipital ROI}} \right)} \right]/\left( {\text{mean counts in occipital ROI}} \right)\)